One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...

Antibodies are immune proteins that our bodies produce to help fight off infection. Where they recognize and bind a pathogen — and how — can give important clues to the microbe’s vulnerabilities. Fred ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

When the body encounters an infectious agent like SARS-CoV-2, it produces antibodies that detect and neutralize it. The antibodies bind to distinct proteins on the virus’s surface called antigens. As ...

Could monoclonal antibodies be the key to tackling the growing problem of antimicrobial resistance? A team led by researchers at the University of Cambridge has developed a monoclonal antibody drug ...

Typically, an antibody consists of two regions that work together. One region is responsible for recognizing and binding a specific target (i.e., the amyloid plaques), while the other region, the Fc ...

The research, from the group of Professor Sophia Karagiannis at King’s College London, could help to better understand the responses of patients who receive this type of therapy. Antibody treatments ...

ST. LOUIS (KTVI) – Monoclonal antibody treatments received a thumbs up from a study by the Mayo Clinic released Monday. The study suggests the treatment can help those who are at high risk of serious ...

Monoclonal antibodies are a type of biologic medication that can treat moderate to severe inflammatory bowel disease (IBD) by targeting specific inflammatory processes in your body. Your doctor might ...

Lipids are the fatty molecules that make up cellular membranes, creating a protective barrier that regulates what enters and exits the cell. Until recently, scientists believed antibodies couldn't ...

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells. Dr. Amany Keruakous sat down for an interview with CURE, in ...